Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
US-11267807-B2 · Mar 8, 2022 · US
This page is not indexed by search engines while we improve data quality.
Beth Isreal Deaconess Medical Center Inc patents
Beth Isreal Deaconess Medical Center Inc holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Mar 28, 2017 |
| Latest publication | Mar 8, 2022 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
High throughput ecg heterogeneity assessment to determine presence of coronary artery stenosis
US-2021059551-A1 · Mar 4, 2021 · US
ATRA for modulating Pin1 activity and stability
US-9968579-B2 · May 15, 2018 · US
Assays and methods of treatment relating to vitamin D insufficiency
US-9606131-B2 · Mar 28, 2017 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
US-11267807-B2 · Mar 8, 2022 · US
High throughput ecg heterogeneity assessment to determine presence of coronary artery stenosis
US-2021059551-A1 · Mar 4, 2021 · US
ATRA for modulating Pin1 activity and stability
US-9968579-B2 · May 15, 2018 · US
Assays and methods of treatment relating to vitamin D insufficiency
US-9606131-B2 · Mar 28, 2017 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 2 |
| Physics | 2 |